The DOI matches its Crossref record; 148 of the 151 references it cites were found in a registry or an index.
Endosomal escape pathways for delivery of biologicals
Open accessAbstract
Despite continuous improvements in delivery systems, the development of methods for efficient and specific delivery of targeted therapeutic agents still remains an issue in biological treatments such as protein and gene therapy. The endocytic pathway is the major uptake mechanism of cells and any biological agents, such as DNA, siRNA and proteins. These agents become entrapped in endosomes and are degraded by specific enzymes in the lysosome. Thus, a limiting step in achieving an effective biological based therapy is to facilitate the endosomal escape and ensure cytosolic delivery of the therapeutics. Bacteria and viruses are pathogens which use different mechanisms to penetrate the membranes of their target cells and escape the endosomal pathway. Different mechanisms such as pore formation in the endosomal membrane, pH-buffering effect of protonable groups and fusion into the lipid bilayer of endosomes have been proposed to facilitate the endosomal escape. Several viral and bacterial proteins have been identified that are involved in this process. In addition, chemical agents and photochemical methods to rupture the endosomal membrane have been described. New synthetic biomimetic peptides and polymers with high efficacy in facilitating the endosomal escape, low pathogenicity and toxicity have been developed. Each strategy has different characteristics and challenges for designing the best agents and techniques to facilitate the endosomal escape are ongoing. In this review, several mechanisms and agents which are involved in endosomal escape are introduced.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,605
ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
Mellman, I., Fuchs, R., & Helenius, A. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.003311 · Cited by 2,045
Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
Kay, M., Glorioso, J., & Naldini, L. (2001) · Nature Medicine · doi:10.1038/83324 · Cited by 1,444
THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS
Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413
Cell Internalization of the Third Helix of the Antennapedia Homeodomain Is Receptor-independent
Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G., & Prochiantz, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18188 · Cited by 1,073
The actions of melittin on membranes
Dempsey, C. E. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(90)90006-x · Cited by 852
Stepwise dismantling of adenovirus 2 during entry into cells
Greber, U. F., Willetts, M., Webster, P. C., & Helenius, A. (1993) · Cell · doi:10.1016/0092-8674(93)90382-z · Cited by 811
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Flagged first, then by citations
3 of the 151 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 1,000
Biodegradable Polymers for Gene-Delivery Applications
Chen, C., Huang, P.-K., Law, W., Chu, C.-H., Chen, N., & Lo, L. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s222419 · Cited by 184
Ma, Z., Yang, Z., Chao, Z., Chen, H., Zhang, Y., Yin, M., Shen, J., & Yan, S. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01336-6 · Cited by 184
Zhang, J., Chen, B., Gan, C., Sun, H., Zhang, J., & Feng, L. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436038 · Cited by 190
Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate
Ginini, L., Billan, S., Fridman, E., & Gil, Z. (2022) · Cells · doi:10.3390/cells11091375 · Cited by 188
Qian, Z., LaRochelle, J. R., Jiang, B., Lian, W., Hard, R. L., Selner, N. G., Luechapanichkul, R., Barrios, A. M., & Pei, D. (2014) · Biochemistry · doi:10.1021/bi5004102 · Cited by 176
Nanocarrier‐Mediated Cytosolic Delivery of Biopharmaceuticals
He, W., Xing, X., Wang, X., Wu, D., Wu, W., Guo, J., & Mitragotri, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910566 · Cited by 179
Targeted Drug Delivery in Cancer Cells with Red-Light Photoactivated Mesoporous Silica Nanoparticles
Mackowiak, S. A., Schmidt, A., Weiss, V., Argyo, C., von Schirnding, C., Bein, T., & Bräuchle, C. (2013) · Nano Letters · doi:10.1021/nl400681f · Cited by 170
Drug Delivery with polymeric nanocarriers-cellular uptake mechanisms
Nelemans, L. C., & Gurevich, L. (2020) · Materials · doi:10.3390/ma13020366 · Cited by 173
Liu, C., Liu, F., Feng, L., Li, M., Zhang, J., & Zhang, N. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.038 · Cited by 168
Progress Towards RNAi-Mediated Insect Pest Management
Baum, J. A., & Roberts, J. K. (2014) · Advances in insect physiology · doi:10.1016/b978-0-12-800197-4.00005-1 · Cited by 168
Smart Polymeric Nanoparticles for Cancer Gene Delivery
Lin, G., Zhang, H., & Huang, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500656v · Cited by 166
Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
Rouet, R., Thuma, B. A., Roy, M. D., Lintner, N. G., Rubitski, D. M., Finley, J. E., Wisniewska, H. M., Mendonsa, R., Hirsh, A., de Oñate, L., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01551 · Cited by 163
A novel cationic niosome formulation for gene delivery to the retina
Puras, G., Mashal, M., Zárate, J., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Diaz-Tahoces, A., Martínez Navarrete, G., Avilés-Trigueros, M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.004 · Cited by 164
Ruenraroengsak, P., & Tetley, T. D. (2015) · Particle and Fibre Toxicology · doi:10.1186/s12989-015-0091-7 · Cited by 164
Manju, S., & Gong, S. (2014) · Materials Today · doi:10.1016/j.mattod.2014.05.002 · Cited by 165
Zhu, Y., Jia, H., Pan, G., Ulrich, N. W., Chen, Z., & Wu, F. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b13672 · Cited by 163
Schönichen, A., Webb, B. A., Jacobson, M. P., & Barber, D. L. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-050511-102349 · Cited by 162
Au, J. L. ‐., Yeung, B. Z., Wientjes, M. G., Lu, Z., & Wientjes, M. G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.002 · Cited by 163
Nanogels for intracellular delivery of biotherapeutics
Li, D., van Nostrum, C. F., Mastrobattista, E., Vermonden, T., & Hennink, W. E. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.020 · Cited by 161
Sharker, S. M., Lee, J. E., Kim, S., Jeong, J. H., In, I., Lee, H., & Park, S. Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.040 · Cited by 158
Tanowitz, M., Hettrick, L. A., Revenko, A. S., Kinberger, G. A., Prakash, T. P., & Seth, P. P. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx960 · Cited by 165
Design of nanocarriers based on complex biological barriers in vivo for tumor therapy
Liu, J., Li, M., Luo, Z. Y., Dai, L., Guo, X., & Cai, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.010 · Cited by 158
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
Xiao, B., & Merlin, D. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.730517 · Cited by 145
Nanomaterial-Enabled Cancer Therapy
Quader, S., & Kataoka, K. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.04.026 · Cited by 159
Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems
Kydd, J. L., Jadia, R., Velpurisiva, P., Gad, A. P., Paliwal, S., & Rai, P. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040046 · Cited by 156
Emerging Methods and Design Principles for Cell‐Penetrant Peptides
Peraro, L., & Kritzer, J. A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201801361 · Cited by 160
Blakney, A. K., Zhu, Y., McKay, P. F., Bouton, C. R., Yeow, J., Tang, J., Hu, K., Samnuan, K., Grigsby, C. L., Shattock, R. J., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c00326 · Cited by 155
A review of lipidation in the development of advanced protein and peptide therapeutics
Menacho‐Melgar, R., Decker, J. S., Hennigan, J. N., & Lynch, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.032 · Cited by 159
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
Luther, D. C., Lee, Y. W., Nagaraj, H., Scaletti, F., & Rotello, V. M. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517746 · Cited by 162
Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles
Ahmad, A., Khan, J. M., & Haque, S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.02.012 · Cited by 155
Niedermayer, S., Weiß, V., Herrmann, A., Schmidt, A., Datz, S., Müller, K., Wagner, E., Bein, T., & Bräuchle, C. (2015) · Nanoscale · doi:10.1039/c4nr07245f · Cited by 151
pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery
Lee, H., Park, H., Noh, G. J., & Lee, E. S. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.141 · Cited by 150
Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications
Tieu, T., Alba, M., Elnathan, R., Cifuentes‐Rius, A., & Voelcker, N. H. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800095 · Cited by 150
Subcellular Performance of Nanoparticles in Cancer Therapy
Liu, C., Han, Y., Kankala, R. K., Wang, S., & Chen, A. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s226186 · Cited by 157
Oligonucleotide Conjugates for Therapeutic Applications
Winkler, J. (2013) · Therapeutic Delivery · doi:10.4155/tde.13.47 · Cited by 149
Hao, N., Jayawardana, K. W., Chen, X., & Yan, M. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/am508219g · Cited by 150
Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery
Natarajan, S. K., & Selvaraj, S. (2014) · RSC Advances · doi:10.1039/c4ra00781f · Cited by 148
Chitosan-coated PLGA nanoparticles: A sustained drug release strategy for cell cultures
Chronopoulou, L., Massimi, M., Giardi, M. F., Cametti, C., Devirgiliis, L. C., Dentini, M., & Palocci, C. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.10.063 · Cited by 148
Dai, X., & Tan, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.09.010 · Cited by 149
Nanoplasmonic optical antennas for life sciences and medicine
Xin, H., Namgung, B., & Lee, L. P. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0033-8 · Cited by 151
Guan, Q., Wang, G.-B., Zhou, L., Li, W., & Dong, Y. (2020) · Nanoscale Advances · doi:10.1039/d0na00537a · Cited by 151
Modulating the immune system through nanotechnology
Dacoba, T. G., Ana, O., Torres, D., Crecente‐Campo, J., & Alonso, M. J. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.007 · Cited by 150
Drug delivery with living cells
Fliervoet, L. A. L., & Mastrobattista, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.021 · Cited by 143
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
Tiwari, P. M., Vanover, D. A., Lindsay, K. E., Bawage, S. S., Kirschman, J. L., Bhosle, S. M., Lifland, A. W., Zurla, C., & Santangelo, P. J. (2018) · Nature Communications · doi:10.1038/s41467-018-06508-3 · Cited by 144
Solid lipid nanoparticles as nucleic acid delivery system: Properties and molecular mechanisms
de Jesus, M. B., & Zuhorn, I. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.010 · Cited by 139
Advances in nanomedical applications: diagnostic, therapeutic, immunization, and vaccine production
El-Sayed, A., & Kamel, M. S. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-06459-2 · Cited by 142
Wang, R., Yin, C., Liu, C., Sun, Y., Xiao, P., Li, J., Yang, S., Wu, W., & Jiang, X. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c09741 · Cited by 140
Liu, Y., He, M., Yuan, Y., Nie, C., Wei, K., Zhang, T., Chen, T., & Chu, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c00288 · Cited by 143
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
Mukalel, A. J., Riley, R., Zhang, R., & Mitchell, M. J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.040 · Cited by 143
Challenges and advances towards the rational design of mRNA vaccines
Pollard, C., Koker, S. D., Saelens, X., Vanham, G. L., & Grooten, J. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.09.002 · Cited by 138
Baral, K. C., & Choi, K. Y. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040397 · Cited by 149
SiRNA delivery with functionalized carbon nanotubes
Varkouhi, A. K., Foillard, S., Lammers, T., Schiffelers, R. M., Doris, E., Hennink, W. E., & Storm, G. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.009 · Cited by 134
Self-citationDNA delivery with hyperbranched polylysine: A comparative study with linear and dendritic polylysine
Kadlecová, Z., Rajendra, Y., Matasci, M., Baldi, L., Hacker, D. L., Wurm, F. M., & Klok, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.019 · Cited by 136
Cellular uptake and intracellular trafficking of oligonucleotides
Juliano, R. L., & Carver, K. A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.005 · Cited by 138
Li, M., Tao, Y., Shu, Y., LaRochelle, J. R., Steinauer, A., Thompson, D. B., Schepartz, A., Chen, Z., & Liu, D. R. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b05694 · Cited by 136
Visualization of self-delivering hydrophobically modified siRNA cellular internalization
Ly, S., Navaroli, D. M., Didiot, M.-C., Cardia, J., Pandarinathan, L., Alterman, J. F., Fogarty, K., Standley, C., Lifshitz, L. M., Bellve, K. D., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1005 · Cited by 132
Biomolecular engineering for nanobio/bionanotechnology
Nagamune, T. (2017) · Nano Convergence · doi:10.1186/s40580-017-0103-4 · Cited by 135
Cheng, G., Tang, F., Gong, G., Zhang, J., Hoi, M. P. M., Lee, S. M., & Wang, R. (2017) · Nanoscale · doi:10.1039/c7nr03611f · Cited by 132
Francia, V., Montizaan, D., & Salvati, A. L. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.25 · Cited by 142
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Hu, M., Li, X., You, Z., Cai, R., & Chen, C. (2023) · Advanced Materials · doi:10.1002/adma.202303266 · Cited by 142
Intracellular delivery of nanocarriers and targeting to subcellular organelles
Jhaveri, A. M., & Torchilin, V. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1086745 · Cited by 131
Zhang, Y., Yang, D., Chen, H., Lim, W. Q., Phua, F. S. Z., An, G., Yang, P., & Zhao, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.023 · Cited by 131
Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing
Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., & Gu, Z. (2015) · Angewandte Chemie · doi:10.1002/ange.201506030 · Cited by 132
Singh, N., Kim, J., Kim, J., Lee, K., Zunbul, Z., Lee, I., Kim, E., Chi, S.-G., & Kim, J. S. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.08.016 · Cited by 133
Nanoplatforms for mRNA Therapeutics
Meng, C., Chen, Z., Li, G., Welte, T., & Shen, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000099 · Cited by 130
Guo, Y., Zhang, X., Sun, W., Jia, H., Zhu, Y., Zhang, X., Zhou, N., & Wu, F. (2019) · Chemistry of Materials · doi:10.1021/acs.chemmater.9b03042 · Cited by 128
Juliano, R. L., Ming, X., Carver, K. A., & Laing, B. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0463 · Cited by 135
Transcytosis of Nanomedicine for Tumor Penetration
Liu, Y., Huo, Y., Yao, L., Xu, Y., Meng, F., Li, H., Sun, K., Zhou, G., Kohane, D. S., & Tao, K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03211 · Cited by 129
A survey on “Trojan Horse” peptides: Opportunities, issues and controlled entry to “Troy”
Shi, N., Qi, X., Xiang, B., & Zhang, Y. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.014 · Cited by 129
He, C., Poon, C. J., Chan, C., Yamada, S. D., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b02486 · Cited by 126
Shu, Y., Shu, D., Haque, F., & Guo, P. (2013) · Nature Protocols · doi:10.1038/nprot.2013.097 · Cited by 126
Drug delivery to macrophages: Challenges and opportunities
Pei, Y., & Yeo, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.014 · Cited by 129
pH-responsive cationic liposome for endosomal escape mediated drug delivery
Rayamajhi, S., Marchitto, J., Nguyen, T. D. T., Marasini, R., Celia, C., & Aryal, S. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.110804 · Cited by 128
Challenge to overcome current limitations of cell-penetrating peptides
Kim, G. C., Cheon, D. H., & Lee, Y. (2021) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2021.140604 · Cited by 129
Ma, D., Bian, H., Gu, M., Wang, L., Chen, X., & Peng, X. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.215677 · Cited by 124
Cai, X., Dong, C., Dong, H., Wang, G., Pauletti, G. M., Pan, X., Wen, H., Mehl, I., Li, Y., & Shi, D. (2012) · Biomacromolecules · doi:10.1021/bm2017355 · Cited by 124
Synthetic nanovaccines for immunotherapy
Luo, M., Samandi, L. Z., Wang, Z., Chen, Z. J., & Gao, J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.033 · Cited by 126
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
Juliano, R. L. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0727 · Cited by 125
Recent advances in DNAzyme-based gene silencing
Fan, H., Zhang, X., & Lu, Y. (2017) · Science China Chemistry · doi:10.1007/s11426-016-0472-1 · Cited by 123
Dong, K., Wang, Z., Zhang, Y., Ren, J., & Qu, X. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b11972 · Cited by 125
Zhao, Z.-X., Gao, S., Wang, J., Chen, C.-J., Zhao, E.-Y., Hou, W., Feng, Q., Gao, L., Liu, X.-Y., Zhang, L., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.067 · Cited by 122
Kilchrist, K. V., Dimobi, S. C., Jackson, M. A., Evans, B. C., Werfel, T. A., Dailing, E. A., Bedingfield, S. K., Kelly, I. B., & Duvall, C. L. (2019) · ACS Nano · doi:10.1021/acsnano.8b05482 · Cited by 124
NIR‐Actuated Ferroptosis Nanomotor for Enhanced Tumor Penetration and Therapy
Hu, Z., Tan, H., Ye, Y., Xu, W., Gao, J., Liu, L., Zhang, L., Jiang, J., Tian, H., Peng, F., et al. (2024) · Advanced Materials · doi:10.1002/adma.202412227 · Cited by 120
Ramasamy, T., Ruttala, H. B., Chitrapriya, N., Poudal, B. K., Choi, J. Y., Kim, S. T., Youn, Y. S., Ku, S., Choi, H., Yong, C. S., et al. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.10.034 · Cited by 120
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 130
Cell penetrating peptides in ocular drug delivery: State of the art
Pescina, S., Ostacolo, C., Gomez-Monterrey, I. M., Sala, M., Bertamino, A., Sonvico, F., Padula, C., Santi, P., Bianchera, A., & Nicoli, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.023 · Cited by 118
Ghorai, S. M., Deep, A., Magoo, D., Gupta, C., & Gupta, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071999 · Cited by 124
Almeida, P. V., Shahbazi, M., Mäkilä, E. M., Kaasalainen, M. H., Salonen, J., Hirvonen, J. J., & Santos, H. A. (2014) · Nanoscale · doi:10.1039/c4nr02187h · Cited by 117
Krishnamurthy, S., Wohlford-Lenane, C., KANDIMALLA, S., Sartre, G., Meyerholz, D. K., Théberge, V., Hallée, S., Duperré, A.-M., Del’Guidice, T., Lepetit-Stoffaes, J.-P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12922-y · Cited by 116
Cell-Penetrating Peptides Escape the Endosome by Inducing Vesicle Budding and Collapse
Sahni, A., Qian, Z., & Pei, D. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00478 · Cited by 118
Guo, Y., Wang, S.-Z., Zhang, X., Jia, H., Zhu, Y., Zhang, X., Gao, G., Jiang, Y., Li, C., Chen, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33831-7 · Cited by 115
Multicomponent Supramolecular Polymers as a Modular Platform for Intracellular Delivery
Bakker, M. H., Lee, C. C., Meijer, E. W., Dankers, P. Y. W., & Albertazzi, L. (2016) · ACS Nano · doi:10.1021/acsnano.5b05383 · Cited by 113
Cai, X., Jin, R., Wang, J., Yue, D., Jiang, Q., Wu, Y., & Gu, Z. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b11545 · Cited by 113
Chitosan-based mucosal adjuvants: Sunrise on the ocean
Xia, Y., Fan, Q., Hao, D., Wu, J., Ma, G., & Su, Z. G. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.101 · Cited by 111
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
Grafals‐Ruiz, N., Ríos-Vicil, C. I., Lozada-Delgado, E. L., Quiñones‐Díaz, B. I., Rivera, R. A. N., Martínez-Zayas, G., Santana‐Rivera, Y., Santiago-Sánchez, G. S., Valiyeva, F., & Vivas‐Mejía, P. E. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s241055 · Cited by 111
How successful is nuclear targeting by nanocarriers?
Tammam, S. N., Azzazy, H. M. E.-S., & Lamprecht, A. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.03.022 · Cited by 108
Xu, X., Jian, Y., Li, Y., Zhang, X., Tu, Z., & Gu, Z. (2014) · ACS Nano · doi:10.1021/nn503118f · Cited by 109
Ramasamy, T., Ruttala, H. B., Sundaramoorthy, P., Poudel, B. K., Youn, Y. S., Ku, S., Choi, H., Yong, C. S., & Kim, J. O. (2018) · NPG Asia Materials · doi:10.1038/s41427-018-0034-5 · Cited by 111
Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs
Johannes, L., & Lucchino, M. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2017.0716 · Cited by 110
Yang, Y., Wang, Z., Peng, Y., Ding, J., & Zhou, W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00010 · Cited by 109
Metadata
- Authors
- Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J.
- Affiliations
- Utrecht University (NL)
- University of Groningen (NL)
- Corresponding author
- Haisma, Hidde J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 151
- Issue
- 3
- Pages
- 220-228
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2008028087
- Cited by
- 1,561
- References
- 151
- Citations by year
- 2026: 82 · 2025: 82 · 2024: 90 · 2023: 94 · 2022: 122 · 2021: 100 · 2020: 123 · 2019: 120 · 2018: 137 · 2017: 111 · 2016: 127 · 2015: 116 · 2014: 98 · 2013: 90 · 2012: 51
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- endosomal escape, endocytosis, lysosomal degradation, protein delivery, gene delivery, siRNA delivery, viral fusion, pH buffering, biomimetic peptides, polymers, biologic therapy
- MeSH terms
- Animals, Cytosol, DNA, Drug Carriers, Endocytosis, Humans, Intracellular Membranes, Membrane Fusion, Models, Biological, Proteins, Endosomes, RNA, Small Interfering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review